CT and clinical assessment in asymptomatic and pre-symptomatic patients with early SARS-CoV-2 in outbreak settings

Abstract

Objectives The early infection dynamics of patients with SARS-CoV-2 are not well understood. We aimed to investigate and characterize associations between clinical, laboratory, and imaging features of asymptomatic and pre-symptomatic patients with SARS-CoV-2. Methods Seventy-four patients with RT-PCR-proven SARS-CoV-2 infection were asymptomatic at presentation. All were retrospectively identified from 825 patients with chest CT scans and positive RT-PCR following exposure or travel risks in outbreak settings in Japan and China. CTs were obtained for every patient within a day of admission and were reviewed for infiltrate subtypes and percent with assistance from a deep learning tool. Correlations of clinical, laboratory, and imaging features were analyzed and comparisons were performed using univariate and multivariate logistic regression. Results Forty-eight of 74 (65%) initially asymptomatic patients had CT infiltrates that pre-dated symptom onset by 3.8 days. The most common CT infiltrates were ground glass opacities (45/48; 94%) and consolidation (22/48; 46%). Patient body temperature ( p < 0.01), CRP ( p < 0.01), and KL-6 ( p = 0.02) were associated with the presence of CT infiltrates. Infiltrate volume ( p = 0.01), percent lung involvement ( p = 0.01), and consolidation ( p = 0.043) were associated with subsequent development of symptoms. Conclusions COVID-19 CT infiltrates pre-dated symptoms in two-thirds of patients. Body temperature elevation and laboratory evaluations may identify asymptomatic patients with SARS-CoV-2 CT infiltrates at presentation, and the characteristics of CT infiltrates could help identify asymptomatic SARS-CoV-2 patients who subsequently develop symptoms. The role of chest CT in COVID-19 may be illuminated by a better understanding of CT infiltrates in patients with early disease or SARS-CoV-2 exposure. Key Points • Forty-eight of 74 (65%) pre-selected asymptomatic patients with SARS-CoV-2 had abnormal chest CT findings. • CT infiltrates pre-dated symptom onset by 3.8 days (range 1–5). • KL-6, CRP, and elevated body temperature identified patients with CT infiltrates. Higher infiltrate volume, percent lung involvement, and pulmonary consolidation identified patients who developed symptoms.

The Potential of Lung Epithelium Specific Proteins as Biomarkers for COVID-19-Associated Lung Injury

“…In addition, one study aimed to investigate and distinguish between the clinical, imaging, and laboratory findings of COVID-19 cases. The researchers found that patients with CT infiltrate had higher KL-6 levels in comparison to patients with no CT infiltrates [ 29 ]. In another recent study, researchers measured KL-6 in COVID-19 patients during hospitalization and 6–9 months after being discharged from the hospital.…”

Chemotherapy During Active SARS-CoV2 Infection: A Case Report and Review of the Literature

“…Another issue is asymptomatic lesions in lungs in CT scan, which were detected in our first patients. This situation is reported in about 30% of asymptomatic SARS-CoV-2 positive patients (36).…”

Systematic review and meta-analysis of the CT imaging characteristics of infectious pneumonia

“…[2020] (21) pointed out that diagnosis based on lung imaging is accurate. The CT imaging characteristics change with the disease condition, suggesting that CT images can be used for real-time diagnosis and evaluation (22).…”